# Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients

> **NCT00171509** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 61 (actual)

## Conditions studied

- Liver Transplant

## Interventions

- **DRUG:** Cyclosporine microemulsion

## Key facts

- **NCT ID:** NCT00171509
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2011-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171509, "Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00171509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*